Activating Compound | Comment | Organism | Structure |
---|---|---|---|
additional information | sEH is specifically up-regulated by angiotensin II | Mus musculus | |
additional information | sEH is specifically up-regulated by angiotensin II | Rattus norvegicus |
Application | Comment | Organism |
---|---|---|
medicine | soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy | Mus musculus |
medicine | soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-(1-methanesulfonyl-piperidin-4-yl)-3-(4-trifluoromethoxy-phenyl)-urea | 0.001 mM markedly inhibits the basal and angiotensin II-induced sEH activity | Mus musculus | |
1-(1-methanesulfonyl-piperidin-4-yl)-3-(4-trifluoromethoxy-phenyl)-urea | 0.001 mM markedly inhibits the basal and angiotensin II-induced sEH activity | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
- |
- |
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
cardiomyocyte | - |
Mus musculus | - |
heart | - |
Rattus norvegicus | - |
Synonyms | Comment | Organism |
---|---|---|
EPHX2 | - |
Mus musculus |
EPHX2 | - |
Rattus norvegicus |
SEH | - |
Mus musculus |
SEH | - |
Rattus norvegicus |